The relationship between ERα and AML first came to light in 1996, when researchers discovered that the ERα CpG island is aberrantly methylated in 86% of all hematopoietic neoplasms and 91% of AML samples (Figure 1) [41]. This evidence concerns the gene ESR1 and hematopoietic and lymphoid cell neoplasm.